Document ID: chunk:federal_register_of_legislation:F2023L00016:reg:9:p4
Version: federal_register_of_legislation:F2023L00016
Segment Type: reg
Provision Reference: reg 9 (pt 4/8)
Character Range: 13516–16565

including doxorubicin;
(b) HER2 inhibitors including trastuzumab; and
(c) tyrosine kinase inhibitors including ibrutinib.
(38)      having glucocorticoid therapy as specified before the clinical onset of atrial fibrillation or atrial flutter, and if the glucocorticoid therapy as specified has ceased or decreased before the clinical onset of atrial fibrillation or atrial flutter, then that onset occurred within 30 days of cessation of therapy;
Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(39)      taking a non-topical, non-steroidal, anti-inflammatory drug, excluding low-dose aspirin, for a continuous period at least 30 days within the 60 days before the clinical onset of atrial fibrillation or atrial flutter;
Note: low-dose aspirin is defined in the Schedule 1 – Dictionary.
(40)      taking a drug from the specified list of drugs, within the 7 days before the clinical onset of atrial fibrillation or atrial flutter;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(41)      taking a bisphosphonate for a continuous period at least 30 days within the 60 days before the clinical onset of atrial fibrillation or atrial flutter;
(42)      inhaling ambient, chronically polluted air as specified for at least 1 year, within the 2 years before the clinical onset of atrial fibrillation or atrial flutter;
Note: ambient, chronically polluted air as specified is defined in the Schedule 1 – Dictionary.
(43)      inhaling ambient, highly polluted air as specified for at least the 30 days before the clinical onset of atrial fibrillation or atrial flutter;
Note: ambient, highly polluted air as specified is defined in the Schedule 1 – Dictionary.
Note: Examples of causes of viral lower respiratory tract infections include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus.
(44)      Having a viral lower respiratory tract infection within the 30 days before the clinical onset of atrial fibrillation or atrial flutter;
Note; Examples of causes of viral lower respiratory tract infections include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus.
(45)      having valvular heart disease at the time of the clinical worsening  of atrial fibrillation or atrial flutter;
Note: valvular heart disease is defined in the schedule 1 Dictionary.
(46)      having ischaemic heart disease at the time of the clinical worsening of atrial fibrillation or atrial flutter;
(47)      having non-infectious myocarditis at the time of the clinical  worsening of atrial fibrillation or atrial flutter;
Note 1: Non-infectious myocarditis can be acute or chronic.
Note 2: Non-infectious myocarditis can be of autoimmune, infiltrative or immunological origin. Examples of causes of non-infectious myocarditis include immune checkpoint inhibitor therapy and giant cell myocarditis.
(48)      having viral myocarditis at the time of the clinical worsening of atrial fibrillation or atrial flutter;
Note 1: Viral myocarditis can be acute